Document Detail


Lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men.
MedLine Citation:
PMID:  20196970     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Dietary guidelines for the prevention of coronary heart disease (CHD) have restricted the intake of foods rich in dietary cholesterol, on the grounds that the dietary cholesterol will increase blood cholesterol. In the case of shellfish, this recommendation may limit the intake of a valuable dietary source of long chain n-3 polyunsaturated fatty acids (LC n-3 PUFA). The objective of this study was to undertake a dietary intervention to determine the effects of cold water prawns on plasma lipids and lipoproteins. METHODS: 23 healthy male subjects were randomised to receive either 225 g of cold water prawns or an equivalent weight of fish ('crab') sticks as a control for 12 weeks in a cross-over design. Blood samples were taken at the beginning and end of each intervention for the determination of plasma lipids and lipoproteins by routine enzymatic assays and iodixanol density gradient centrifugation respectively. RESULTS: The diets were well matched for the intake of total energy and macronutrients, and body weight remained stable throughout the study. The prawn intervention increased the intake of dietary cholesterol to 750 mg/d against 200 mg/d on the control. The intake of LC n-3 PUFA from prawns was estimated to be between 0.5-0.7 g/d. The consumption of prawns produced no significant effects on the concentration of plasma total or LDL cholesterol, triacylglycerol, HDL cholesterol or apolipoproteins A-I and B relative to the control, or within each intervention group over time. There was also no significant effect on LDL density (particle size) relative to the control, or any difference between and within treatments in total plasma lipoprotein profiles by density gradient centrifugation. CONCLUSION: These findings provide evidence to suggest that the consumption of cold water prawns, at least in healthy, male subjects, should not be restricted on the grounds of this seafood producing an adverse effect on plasma LDL cholesterol.
Authors:
C Isherwood; M Wong; W S Jones; I G Davies; B A Griffin
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2010-02-25
Journal Detail:
Title:  Cellular and molecular biology (Noisy-le-Grand, France)     Volume:  56     ISSN:  1165-158X     ISO Abbreviation:  Cell. Mol. Biol. (Noisy-le-grand)     Publication Date:  2010  
Date Detail:
Created Date:  2010-03-03     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216789     Medline TA:  Cell Mol Biol (Noisy-le-grand)     Country:  France    
Other Details:
Languages:  eng     Pagination:  52-8     Citation Subset:  IM    
Affiliation:
Faculty of Health & Medical Sciences, University of Surrey, Guildford, Surrey, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apolipoproteins / blood*
Cholesterol, HDL / blood*
Cholesterol, LDL / blood*
Cross-Over Studies
Fatty Acids, Omega-3 / administration & dosage*
Humans
Male
Penaeidae*
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Apolipoproteins; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Fatty Acids, Omega-3; 0/Triglycerides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  EFFECTS OF MARINE N-3 FATTY ACIDS ON CIRCULATING LEVELS OF SOLUBLE ADHESION MOLECULES IN PATIENTS WI...
Next Document:  OMEGA-3 FATTY ACIDS, INFLAMMATION AND ANGIOGENESIS: BASIC MECHANISMS BEHIND THE CARDIOPROTECTIVE EFF...